ZEALAND PHARMA AS
- Country
- 🇩🇰Denmark
- Ownership
- -
- Established
- 1998-01-01
- Employees
- 150
- Market Cap
- $9.1B
A Research Study Looking at the Safety of Single Doses of ZP9830 and How it Works in the Body of Healthy Participants
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 92
- Registration Number
- NCT06682975
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, CL, Netherlands
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 480
- Registration Number
- NCT06662539
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 84
- Registration Number
- NCT06000891
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 68
- Registration Number
- NCT05613387
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D
- First Posted Date
- 2022-05-18
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 8
- Registration Number
- NCT05378672
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸Indiana University School of Medicine, Indianapolis, Indiana, United States
🇺🇸Cook Childrens Health Care System, Fort Worth, Texas, United States
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants
- Conditions
- Interventions
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 64
- Registration Number
- NCT05096598
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany
The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 12
- Registration Number
- NCT04991311
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
- First Posted Date
- 2021-05-11
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 129
- Registration Number
- NCT04881825
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Universitätsklinikum Frankfurt, Frankfurt, Germany
Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
- Conditions
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Zealand Pharma
- Registration Number
- NCT04824872
A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- Zealand Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT04612517
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany